India · Delayed Price · Currency is INR Revance Therapeutics Statistics
Total Valuation
BOM:532466 has a market cap or net worth of INR 739.66 billion. The enterprise value is 697.28 billion.
| Market Cap | 739.66B |
| Enterprise Value | 697.28B |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
BOM:532466 has 86.90 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 86.90M |
| Shares Outstanding | 86.90M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 13.00% |
| Float | 23.47M |
Valuation Ratios
The trailing PE ratio is 30.91 and the forward PE ratio is 27.42.
| PE Ratio | 30.91 |
| Forward PE | 27.42 |
| PS Ratio | 10.63 |
| PB Ratio | 10.95 |
| P/TBV Ratio | 12.04 |
| P/FCF Ratio | 36.71 |
| P/OCF Ratio | 35.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.67, with an EV/FCF ratio of 34.61.
| EV / Earnings | 29.00 |
| EV / Sales | 10.02 |
| EV / EBITDA | 22.67 |
| EV / EBIT | 23.19 |
| EV / FCF | 34.61 |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.95 |
| Quick Ratio | 4.32 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 32.92% and return on invested capital (ROIC) is 25.58%.
| Return on Equity (ROE) | 32.92% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 25.58% |
| Return on Capital Employed (ROCE) | 40.72% |
| Revenue Per Employee | 8.65M |
| Profits Per Employee | 2.99M |
| Employee Count | 8,045 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532466 has paid 9.39 billion in taxes.
| Income Tax | 9.39B |
| Effective Tax Rate | 28.07% |
Stock Price Statistics
The stock price has decreased by -13.26% in the last 52 weeks. The beta is 0.10, so BOM:532466's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -13.26% |
| 50-Day Moving Average | 8,913.84 |
| 200-Day Moving Average | 9,582.71 |
| Relative Strength Index (RSI) | 41.50 |
| Average Volume (20 Days) | 5,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532466 had revenue of INR 69.58 billion and earned 24.05 billion in profits. Earnings per share was 275.35.
| Revenue | 69.58B |
| Gross Profit | 36.46B |
| Operating Income | 30.06B |
| Pretax Income | 33.43B |
| Net Income | 24.05B |
| EBITDA | 30.52B |
| EBIT | 30.06B |
| Earnings Per Share (EPS) | 275.35 |
Balance Sheet
The company has 42.75 billion in cash and 369.00 million in debt, giving a net cash position of 42.38 billion or 487.66 per share.
| Cash & Cash Equivalents | 42.75B |
| Total Debt | 369.00M |
| Net Cash | 42.38B |
| Net Cash Per Share | 487.66 |
| Equity (Book Value) | 67.52B |
| Book Value Per Share | 777.02 |
| Working Capital | 52.09B |
Cash Flow
In the last 12 months, operating cash flow was 20.59 billion and capital expenditures -440.00 million, giving a free cash flow of 20.15 billion.
| Operating Cash Flow | 20.59B |
| Capital Expenditures | -440.00M |
| Free Cash Flow | 20.15B |
| FCF Per Share | 231.82 |
Margins
Gross margin is 52.40%, with operating and profit margins of 43.21% and 34.56%.
| Gross Margin | 52.40% |
| Operating Margin | 43.21% |
| Pretax Margin | 48.05% |
| Profit Margin | 34.56% |
| EBITDA Margin | 43.86% |
| EBIT Margin | 43.21% |
| FCF Margin | 28.96% |
Dividends & Yields
This stock pays an annual dividend of 265.00, which amounts to a dividend yield of 3.11%.
| Dividend Per Share | 265.00 |
| Dividend Yield | 3.11% |
| Dividend Growth (YoY) | 10.42% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 95.71% |
| Buyback Yield | -0.15% |
| Shareholder Yield | 2.95% |
| Earnings Yield | 3.25% |
| FCF Yield | 2.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 5, 2003. It was a forward split with a ratio of 2.
| Last Split Date | Sep 5, 2003 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
BOM:532466 has an Altman Z-Score of 30.29 and a Piotroski F-Score of 2.
| Altman Z-Score | 30.29 |
| Piotroski F-Score | 2 |